Bristol-Myers Squibb Company income statement & cash flow
In the fiscal year ended Dec 31, 2025, Bristol-Myers Squibb Company reported net income of $7.05B on revenue of $48.19B. Operating cash flow was $14.16B and capital expenditures were $1.31B, leaving $12.85B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.43B | $20.78B | $22.56B | $26.14B | $42.52B | $46.38B | $46.16B | $45.01B | $48.30B | $48.19B |
| Gross profit | $14.48B | $14.68B | $16.09B | $18.07B | $30.75B | — | — | — | — | — |
| Net income | $4.46B | $1.01B | $4.92B | $3.44B | −$9.02B | $6.99B | $6.33B | $8.03B | −$8.95B | $7.05B |
| Diluted EPS | $2.65 | $0.61 | $3.01 | $2.01 | −$3.99 | $3.12 | $2.95 | $3.86 | −$4.41 | $3.46 |
| Operating cash flow | $3.06B | $5.28B | $7.07B | $8.21B | $14.05B | $16.21B | $13.07B | $13.86B | $15.19B | $14.16B |
| Capital expenditures | $1.22B | $1.05B | $951.00M | $836.00M | $753.00M | $973.00M | $1.12B | $1.21B | $1.25B | $1.31B |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | — | — | 14.6% |
| Dec 2024 | — | — | -18.5% |
| Dec 2023 | — | — | 17.8% |
| Dec 2022 | — | — | 13.7% |
| Dec 2021 | — | — | 15.1% |
Source: SEC EDGAR XBRL company facts for CIK 14272 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.